a. Shanghai Key Laboratory of New Drug Design, State Key Laboratory of Bioreactor Engineering, School of Pharmacy, East China University of Science & Technology, Shanghai, China;
b. Innovation Center for AI and Drug Discovery, School of Pharmacy, East China Normal University. Shanghai 200062, China;
c. Lingang Laboratory, Shanghai 200031, China
Funds:
This work was supported in part by the National Natural Science Foundation of China (Grant Nos.: 82425104 and 82173690), the National Key R&
D Program of China (Grant Nos: 2022YFC3400501 and 2022YFC3400504), and the Shanghai Rising-Star Program, China (Grant No: 23QA1402800).
Understanding the metabolism of endogenous and exogenous substances in the human body is essential for elucidating disease mechanisms and evaluating the safety and efficacy of drug candidates during the drug development process. Recent advancements in artificial intelligence (AI), particularly in machine learning (ML) and deep learning (DL) techniques, have introduced innovative approaches to metabolism research, enabling more accurate predictions and insights. This paper emphasizes computational and AI-driven methodologies, highlighting how ML enhances predictive modeling for human metabolism at the molecular level and facilitates integration into genome-scale metabolic models at the omics level. Challenges remain such as data heterogeneity and model interpretability. This work aims to provide valuable insights and references for researchers in drug discovery and development, ultimately contributing to the advancement of precision medicine.